SEC Form D · Amendment · filed November 5, 2018
BioQ Pharma Inc
Location
SAN FRANCISCO, CA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Mark J. Ehlert · San Francisco, CADirectorJoshua W. Kriesel · San Francisco, CAExec · DirectorChristopher J. Portman · San Francisco, CADirectorLlew J. Keltner · San Francisco, CADirectorDaniel J. Tasse · San Francisco, CADirectorNorvall W. Jasper, Jr · San Francisco, CADirectorRichard J. Nesbit · San Francisco, CADirectorRon W. Pauli · San Francisco, CAExecDavid F. Ogens · New York, NYDirectorShiraz Y. Kajee · New York, NYDirectorVor Capital LLP · London, United KingdomExecJohn R. Kline · New York, NYDirectorJohn P. Malfettone · New York, NYDirectorRobert A. Hamwee · New York, NYDirectorAlfred F. Hurley, Jr · New York, NYDirectorAdam B. Weinstein · New York, NYExec · DirectorJames Conway · Sarasota, FLExecCarleton Miller · Sarasota, FLDirectorRoger Branton · Sarasota, FLDirectorKeith Brown · Carlsbad, CADirectorKevin Li · Carlsbad, CADirectorKirk Malloy · Carlsbad, CADirectorFred D. Hassan · Germantown, MDDirectorVinita D. Gupta · Germantown, MDExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗